Kyla Hildebrand

Dr. Kyla Hildebrand is a Canadian allergist and clinical immunologist based in Vancouver, British Columbia. She is notable in the COVID-19 pandemic for her role in approving COVID-19 vaccines on the National Advisory Committee on Immunization (NACI).

Hildebrand completed medical school at the University of Manitoba, Pediatrics Residency at the University of Alberta, and a fellowship in Clinical Immunology and Allergy at the University of Toronto. She completed a Master of Science in Community Health at the University of Toronto and was the 2010 recipient of the Royal College of Physicians and Surgeons of Canada Fellowship for Studies in Medical Education.

Hildebrand is a researcher at the BC Children's Hospital Research Institute.¹⁾ She is also a clinical associate professor in the Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, at the University of British Columbia.²⁾